Abstract:Objective To establish and validate an ultra performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS)method for quantification of MRX-I,a new oxazolidinone antibacterial agent,in human plasma and urine.Methods Chromatographic separation was performed on a Waters ACQUITY UPLC BEH C8 column using an isocratic elution.The mo-bile phase consisted of acetonitrile and water (40∶60,v/v).Quantitative analysis was conducted in the multiple reaction moni-toring mode.Linezolid was used as an internal standard.Liquid-liquid extraction with ethyl acetate was used to remove impuri-ties in the plasma and urine samples.The method was validated in terms of matrix effect,recovery,precision,accuracy and stability.Results The calibration curves were linear within the range of 0.005 00-1 .00 mg/L.The lower limit of quantification was 0.005 00 mg/L for both plasma and urine samples.Retention time was less than 1 .5 min for both MRX-I and internal standard in plasma and urine.The ma-trix effect factors of plasma and urine for MRX-I was 90.4%±8.2% and 82.7%±7.9%,respectively.The recovery of MRX-I was 112.8% ± 13.4% from plasma and 105.6% ± 13.4% from urine samples,respectively.The inter- and intra-day accuracy of MRX-I was 98.9%-105.0% and 96.5%-102.6% in plasma samples,and 92.7%-98.6% and 95.1 %-105.7% in urine samples.MRX-I was stable for 24 h at room tem-perature,48 h in automatic sampler after pretreatment,and stable after 3 freeze-thaw cycles in plasma and urine.MRX-I was also stable at-40℃for eight months in plasma and six months in urine,respectively.Conclusions The UPLC-MS/MS method established in this study shows high sensitivity and specificity for determination of MRX-I in human plasma and urine.The re-sults of validation are consistent with the requirement of bioanalytical method validation.

Development of a New Rapid, Economical and Eco-Friendly HPLC Method for in Vitro and in Vivo Determination of Zolmitriptan.

[HPLC Determination of Zolmitriptan and Its Related Substances].

Validated green and white RP-HPLC method for the estimation of Zolmitriptan in marketed dosage form

Study on Determination of Zolmitriptan in Rat Plasma by HPLC

High-performance Liquid Chromatographic Analysis of Zolmitriptan in Human Plasma Using Fluorescence Detection.

Determination of Zolmitriptan in Human Plasma by High-Performance Liquid Chromatography-Electrospray Mass Spectrometry and Study on Its Pharmacokinetics

HPLC-MS determination of zolmitriptan in human plasma and research of its bioequivalence

Quantification of Zolmitriptan in Plasma by High-Performance Liquid Chromatography-Electrospray Ionization Mass Spectrometry.

Determination of Zolmitriptan in Human Plasma by HPLC-MS and Study on Bioequivalence of Domestic and Import Zolmitriptan Tablets

LC-MS/MS Determination of Zolmitriptan and Its Active Metabolite N-desmethyl-zolmitriptan in Human Plasma

Development And Validation Of A Selective And Robust Lc-Ms/Ms Method For High-Throughput Quantifying Rizatriptan In Small Plasma Samples: Application To A Clinical Pharmacokinetic Study

Simultaneous Determination of Hyzetimibe and Its Main Active Metabolite in Plasma by LC-MS/MS and Its Application in PK Study.

Determination of related substances in Zolmitriptan by HPLC

New Method Development for Hydroxyzine Determination: Application in Stability Studies, Pharmaceutical Formulations, and Humane Serum

A QbD-led simple and sensitive RP-UHPLC method for simultaneous determination of moxifloxacin, voriconazole, and pirfenidone: An application to pharmaceutical analysis

Development and Validation of a RP-HPLC Method for Determination of Pidotimod in Plasma and its Efficient Application to a Pharmacokinetic Study

Development and Validation of a Rapid and Robust LC-MS/MS Method for Quantifi-Cation of a New Oxazolidinone Antibiotic MRX-I in Human Plasma and Urine

Chromatographic method development and validation for the determination of valsartan in biological fluid

Development and Validation of a Quantification Method for Ziyuglycoside I and II in Rat Plasma: Application to Their Pharmacokinetic Studies.

The Development and Validation of the Accurate and Sensitive HPLC Method for Quantification of Mizoribine in Human Plasma and Its Clinical Applications

Development and Validation of an LC-MS/MS Method for the Determination of a Novel Thienoquinolin Urea Transporter Inhibitor PU-48 in Rat Plasma and Its Application to a Pharmacokinetic Study.